Target intelligence / Profile preview

Cell membrane fluidity regulation

Molecular classification
Other
01

Overview

Cell membrane fluidity regulation refers to the control and maintenance of the physical state—specifically the viscosity—of the lipid bilayer that forms biological membranes. Fluidity is determined by several factors including temperature, fatty acid composition (degree of saturation), cholesterol content, and presence or absence of specific lipids such as sphingomyelin. Increased unsaturated fatty acids introduce kinks into phospholipid tails, preventing tight packing and thus increasing fluidity. Cholesterol acts as a bidirectional regulator; at high temperatures it stabilizes membranes by raising melting points, while at low temperatures it prevents clustering and stiffening[1][2][5]. Membrane proteins can also influence local or global bilayer dynamics. Proper regulation is essential for processes like signal transduction, vesicle trafficking, protein diffusion within the plane of the membrane, phagocytosis, and maintaining selective permeability[1][3]. While drugs can modulate these properties indirectly—for example through altering cholesterol levels—cell membrane fluidity itself is not considered a discrete molecular target such as a receptor or enzyme. Note: "Cell membrane fluidity regulation" describes a process or property rather than an individual molecule/receptor/protein. It does not correspond to a canonical drug target but rather encompasses multiple molecular determinants that collectively regulate this biophysical characteristic[1][2].

Other names
Membrane fluidity regulationRegulation of membrane viscosityControl of lipid bilayer fluidity
02

Mechanism of action

Alteration of lipid composition (e.g., increasing unsaturated fatty acids increases fluidity); Modulation by cholesterol content (cholesterol stabilizes or destabilizes membranes depending on temperature)

03

Biological functions

Regulation of cell signalingModulation of membrane protein mobilityControl of endocytosis and exocytosisMaintenance of cell structure and integrity
04

Disease associations

Other (altered membrane fluidity is implicated in various diseases but not as a direct therapeutic target)
05

Safety considerations

Non-specific effects if targeting overall membrane properties; potential for widespread cellular dysfunction
06

Interacting drugs

Losartan (known to alter membrane viscosity)

1 more in the full profile.

Beyond the preview

Go deeper on Cell membrane fluidity regulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell membrane fluidity regulation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call